Abstract |
|
Authors | Uffe Høgh Olesen, Annemette V Thougaard, Peter Buhl Jensen, Maxwell Sehested |
Journal | Molecular cancer therapeutics
(Mol Cancer Ther)
Vol. 9
Issue 6
Pg. 1609-17
(Jun 2010)
ISSN: 1538-8514 [Electronic] United States |
PMID | 20515945
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Acrylamides
- Antineoplastic Agents
- Biomarkers, Tumor
- N-(4-(1-benzoylpiperidin-4-yl)butyl)-3-(pyridin-3-yl)acrylamide
- Piperidines
- RNA, Messenger
- NAD
- Niacin
- Nicotinamide Phosphoribosyltransferase
|
Topics |
- Acrylamides
(administration & dosage, pharmacology, toxicity)
- Animals
- Antineoplastic Agents
(administration & dosage, pharmacology)
- Antineoplastic Combined Chemotherapy Protocols
(pharmacology)
- Biomarkers, Tumor
(metabolism)
- Cell Death
(drug effects)
- Cell Line, Tumor
- Cytoprotection
(drug effects)
- Dose-Response Relationship, Drug
- Gene Expression Regulation, Enzymologic
(drug effects)
- Humans
- Maximum Tolerated Dose
- Mice
- NAD
(biosynthesis)
- Niacin
(administration & dosage, pharmacology)
- Nicotinamide Phosphoribosyltransferase
(antagonists & inhibitors)
- Organ Specificity
(drug effects)
- Piperidines
(administration & dosage, pharmacology, toxicity)
- RNA, Messenger
(genetics, metabolism)
- Substrate Specificity
(drug effects)
- Xenograft Model Antitumor Assays
|